Acceptance of Human Papillomavirus Vaccination Among Californian Parents of Daughters: A Representative Statewide Analysis

Influence of parent characteristics and disease outcome framing on HPV vaccine acceptability among rural, Southern women

“…Rural, Southern women in this study showed strong interest in vaccinating adolescent daughters against HPV, consistent with findings in other United States populations [4][5][6]. Older women expressed lower intentions to provide the HPV vaccine to their female adolescents than younger women did, and most women were less interested in vaccinating themselves than their daughters.…”

“…Although research shows that parents are generally supportive of vaccinating their adolescent children against HPV infection [4][5][6], many gaps in the literature still exist. Since most acceptability studies have been conducted in urban settings, the literature offers little insight into vaccination intentions among rural populations [7].…”

Fathers’ intentions to accept human papillomavirus vaccination for sons and daughters: exploratory findings from rural Honduras

“…This finding challenges stereotypes that fathers in conservative, largely Catholic societies would oppose HPV vaccination due to concerns about promoting sexual activity. This is consistent with prior studies that demonstrate lack of a definitive link between sexual and religious attitudes of parents and vaccine decision making (Bair et al 2008;Constantine and Jerman 2007;Dinh et al 2007).…”

“…Thus fathers may have been motivated to prevent a disease that they had encountered in their community. In addition, Latin American nationals and Latino immigrants often hold favorable opinions toward vaccines in general (Bair et al 2008;Constantine and Jerman 2007;Watts et al 2009), so the Honduran fathers we interviewed may have perceived that the HPV vaccine would improve the health similar to other vaccines. Finally, the high rate of sexually transmitted infections among our participants may have contributed toward favorable attitudes toward a vaccine specifically targeting a sexually transmitted infection.…”

Increasing fear of adverse effects drops intention to vaccinate after the introduction of prophylactic HPV vaccine

“…The most recent example is the vaccine against novel influenza A (H1N1), where, despite the acutely threatening nature of the condition and the high demand for a vaccine, the actual coverage rates after the vaccine became available remained generally low [15,16]. It appears that public uptake generally depends on a balance between fear of the disease and fear of the potential adverse effects of the vaccine [15,[17][18][19].…”